Amid historical and structural barriers, “quality cancer treatment for all” is a simple credo that is not easy to put into action. Cancer is recognized as a leading cause of death, accounting for more than 10 million deaths globally in 2020, according to the World Health Organization. Globally, people with
Life Sciences
지난 블로그 포스팅 #1편에서는 임상시험 전 과정에 참여한 내.외부 모든 이해관계자가 임상시험 데이터에 쉽게 접근하여 진행 상황을 파악할 수 있도록 지원하는 SAS Visual Analytics 솔루션의 기능을 소개해 드렸습니다. 이번 포스팅에서는 이러한 AI기반의 SAS Visual Analytics 분석 솔루션을 활용하여 임상시험 SDTM 데이터의 탐색 및 시각화 리포트의 활용에 대해 알아보겠습니다. Clinical Data
임상시험을 비롯한 모든 업무에서 분석은 필수이며, 점점 고급분석을 필요로하고 있습니다. 이번 블로그 포스팅은 2편으로 나누어 1편에서는 임상시험 전 과정에 참여한 내.외부 모든 이해관계자가 임상시험 데이터에 쉽게 접근하여 진행 상황을 파악할 수 있도록 지원하는 SAS Visual Analytics 솔루션의 기능을 소개합니다. 이어 2편에서는 임상시험의 SDTM 데이터를 활용하여 SAS Visual Analytics 솔루션에 어떻게
Melhorar a vida das pessoas com base em dados, é um dos nossos principais objetivos no SAS. É neste sentido, que uma das categorias dos Curiosity Data Science Iberian Awards, que organizámos este ano pela primeira vez em conjunto com a SPAIN IA e a Data Science Portuguese Association (DSPA),
How long do dogs live? ... That's a good/tough question. Some live longer than others, but what are the determining factors? Let's throw some data to this problem, and see if we can fetch some answers! But before we get started, how about a random picture to get you into
We’ve all experienced the value that innovation has brought to our lives. The cloud, enormous data sets and more accurate AI modeling have enabled many organizations to bring new products and services to market in ways we could not have imagined 20 years ago. The health care and life sciences
Collaboration in the cloud is definitely the next big thing from my perspective for life sciences organisations.
FDA, 의약품 평가 및 연구 센터 위해 SAS 고급분석 및 AI 기술 도입 미국 식품의약국(FDA)은 SAS® Viya® 플랫폼 내 자연어 처리, 인공지능 및 머신러닝 기능 등을 기반으로 새로운 도약을 위해 SAS와 40년 파트너십을 연장하기로 했습니다. 향후 5 년간 4,990 만 달러(약 560억원)에 달하는 총괄 구매 계약(BPA)을 통해 SAS는 FDA에서 진행중인
Safety, efficacy, speed and costs must all be prioritized and balanced in the delivery of life-changing therapies to patients. A drug that's quickly and cost-efficiently delivered to market, but isn’t effective and safe is unacceptable. An effective, safe drug that doesn’t get to patients in time to save lives has
"I was very impressed by how epidemiologists, analytical experts, architects, programmers and others were working together."
Jamais l’industrie pharmaceutique et le secteur de la santé n’ont été l’objet d’autant d’attention de la part des professionnels certes, mais aussi des médias, des non-professionnels, malades ou non malades, internautes. Le monde entier à les yeux rivés sur chaque post, publication, innovation, news, fakes news. De la façon de
CTOからのあなたへの招待状 ~リアルワールドのためのグローバルデータサイエンス・ハッカソンイベントを開催~ 世界中のどこかにいる有志のあなたへ 従来からSASをご愛顧頂いている皆様、そして、これから新たに出会う皆様、こちらはSAS Instituteでございます。今回は、非常にInspired+Greatなニュースをお届けさせていただきます。 それは、SASがグローバルでHackinSASというデータサイエンス・ハッカソンイベントを開催するということです! 今回のイベントでは、グローバルで参加者を募集しています。もちろん、従来のSASユーザのみならず、開発者やオープンソースユーザ、学生の方々、Startup企業の方々、またはテクニカルパートナーの方々、誰でも参加可能なイベントです。また、今回イベントの主旨としては、皆様の周りにあるデータを用いて、そのデータから有用な情報を得て、リアルワールドのビジネス課題・社会問題を解決するためのソリューションや、よりクリエイティブなデータの使い道を発見することを目指しています。詳細は後述するイベント詳細情報をご参照ください。 SASは長年、データから有用な情報を得て、その情報をリアルワールドの社会問題・環境問題、そしてビジネス課題解決に貢献できる製品やソリューション、そしてサービスを開発し、そのナレッジを貯蓄してきました。また、たくさんのユーザの方々との関わり合いの中で得られた情報などもとても有益なものでした。ハッカソンイベントはまさに、そのような様々なナレッジや発想を持っている皆様に切磋琢磨できる舞台を提供しています。 まずSASのエグゼクティブ・バイス・プレジデント兼最高執行責任者兼最高技術責任者のOliver Schabenbergerからのメッセージをご覧ください。 クリック! では、イベント詳細情報は下記となります。 1.開催スケジュール ハッカソン全期間スケジュール 2020年12月17日-2021年2月15日 チームとテーマの登録期間。 この期間中に、あなたのチームを結成しましょう。そして、課題を定義し、サマリをご提出ください。 2021年1月―2月 リソース確保期間。 この期間中に、ハッカソンをするための無料イネーブルメントリソースを活用して、優位に立ちましょう。 2021年3月 ハッカソン正式開始期間。 この期間中に、あなたとチームメンバーの創造性を輝かせる時がきます。データとSASを使って課題を解決しましょう。 2021年4月 最終ラウンド期間。 最終ラウンドに参加できるチームが選定され、SAS Vector Labsチーム(SAS Innovation Hub)に紹介され、更なる課題解決のためのアプリケーション開発を行うことが可能です。 Virtual SAS® Global Forum 2021(2021年春に開催予定) 2021年のSAS Global Forumで優勝者の結果が公開されます! 事前ライブキックオフミーティング 2021年1月13日13:00 – 14:00オンラインで開催 開催概要: SASのエグゼクティブ・バイス・プレジデント兼最高執行責任者兼最高技術責任者のOliver Schabenbergerが、この他に類を見ないグローバルハッカソンとは何か、そしてビジネスの課題解決や社会貢献のためにアナリティクス、AI、オープンソースをどのように創造的な方法で活用できるのかについてお話します。 ハッカソンズ・インターナショナルのCEOであるAngela Bee ChanとSASのプロダクト・マーケティング・マネージャーであるMarinela Profiの魅力的な対談が行われます。彼らはこのハッカソンの中でできるコラボレーションと、HackinSASが単なる競争以上の価値あるものであるかをお話します。
Do you need to see how long patients have been treated for? Would you like to know if a patient’s dose has changed, or if the patient experienced any dose interruptions? If so, you can use a Napoleon plot, also known as a swimmer plot, in conjunction with your exposure
La pandémie COVID-19 a mis en évidence des défis majeurs dans le secteur des sciences de la vie, mais elle a également identifié de réelles opportunités de changement et de modernisation. A l’avenir, il ne fait aucun doute que les données et l’analytique auront un rôle beaucoup plus important à
The pandemic may have other implications for manufacturing. For example, we could see factories moving away from a reliance on physical labour.
How can organizations be more resilient during an uncertain business and public health situation? Lessons learned from organizations at the front lines of crisis response reinforce the importance of good analytic governance. These leading organizations have shown us that the fundamentals of the analytic life cycle – data, discovery and
L'Intelligence Artificielle (IA) et l'analytique aident à la détection des premiers symptômes indicateurs d'une possible épidémie. Ce qui contribue largement à limiter la propagation d'un virus. Il faut pouvoir compter sur des techniques analytiques capables de repérer des événements rares mais significatifs, comme une hausse de l'absentéisme dans une école
The current state of policy enforcement during an infectious disease pandemic is mostly reactive. Public health officials track changes in active cases, identify hot-spots and enforce containment policies primarily based on geographic proximity. By combining telecommunications data -- which we turn into mobility information -- with public health data of
The COVID-19 pandemic has revealed the vulnerability of pharmaceutical supply chains. Pharma companies are focusing on risk management to improve the resilience of their networks. Most of the measures they will take, including on-shoring, over capacities and redundancies, will lead to higher costs. To decrease inventory levels across these new
In May, I joined several SAS colleagues, academics, clinicians, pharmaceutical companies, and other information and technology specialists for the first-ever IMI PIONEER Hackathon for prostate cancer research. A few weeks later, as I watched the SpaceX launch on TV, it occurred to me that space trips and cancer research have
While working at the Rutgers Robert Wood Johnson Medical School, I had access to data on over ten million visits to emergency departments in central New Jersey, including ICD-9 (International Classification of Disease – 9th edition) codes along with some patient demographic data. I also had the ozone level from
바이러스는 어떻게 확산될까요? 전염 가능성을 높이는 요인은 무엇일까요? 사람에 따라 증상이 다른 이유는 무엇일까요? 어떤 치료법이 효과 있을까요? 백신 개발은 얼만큼 진행된 걸까요? 매일 새로운 연구 결과가 발표되고 세계 각지에서 연구 프로젝트가 진행되고 있지만, 코로나19와 신종 코로나바이러스에 대해서 우리는 여전히 아는 것보다 모르는 것이 더 많습니다. 그리고 풀어야 할 궁금증은
Las organizaciones de salud, los gobiernos y la población en general siguen concentrando sus esfuerzos en reducir la velocidad de propagación del COVID-19. Las medidas de prevención implementadas en todo el mundo, como el confinamiento y el distanciamiento social, han contribuido a ralentizarla. No obstante, continúan reportándose altos índices de
Governments, industry and academia are coming together to find solutions to the problems caused by COVID-19, which emerged in the city of Wuhan, China, in December 2019. Unsurprisingly, the life sciences and health care sectors are at the heart of the work. Health care may make most of the headlines,
We've set up a Covid-19 task force to support you during this crisis. We offer free consultations and can provide recommendations.
In some cases, recovery provides immunity to future infections, however the evidence currently available for COVID-19 cannot confirm this immunity stage.
By this point you may be wondering whether the so-called hill that represents the move to operationalization may actually be a mountain.
Nos primeiros dias e semanas de qualquer problema de saúde global generalizado, particularmente num surto de rápida evolução como o coronavírus, existem muitas incógnitas. A visualização de dados pode ser um bom ponto de partida para perceber tendências e transformar dados dispersos em algo útil. A capacidade de visualizar a
인류의 건강을 위협하는 문제, 특히 코로나바이러스(COVID-19)처럼 빠르게 전파되는 질병이 확산되는 초기 단계에는 예상할 수 없는 많은 변수들이 존재합니다. 이러한 단계에서 데이터 시각화를 활용하면 빠르게 추세를 파악하고 단편적인 데이터들로부터 유의미한 결과를 도출할 수 있습니다. 바이러스 경로 시각화는 사람들에게 경각심을 일깨우고 바이러스의 영향력을 알림으로써, 궁극적으로 질병 예방 활동에 도움이 될 수 있을
In the early days and weeks of any widespread global health concern, particularly in a fast-moving outbreak like the coronavirus, there are many unknowns. Data visualization can be a good starting point to understand trends and piece data points together into a meaningful story. The ability to visualize the spread